Two Prenylated Chalcones, 4-Hydroxyderricin, and Xanthoangelol Prevent Postprandial Hyperglycemia by Promoting GLUT4 Translocation via the LKB1/AMPK Signaling Pathway in Skeletal Muscle Cells
- PMID: 38267744
- DOI: 10.1002/mnfr.202300538
Two Prenylated Chalcones, 4-Hydroxyderricin, and Xanthoangelol Prevent Postprandial Hyperglycemia by Promoting GLUT4 Translocation via the LKB1/AMPK Signaling Pathway in Skeletal Muscle Cells
Abstract
Scope: Stimulation of glucose uptake in the skeletal muscle is crucial for the prevention of postprandial hyperglycemia. Insulin and certain polyphenols enhance glucose uptake through the translocation of glucose transporter 4 (GLUT4) in the skeletal muscle. The previous study reports that prenylated chalcones, 4-hydroxyderricin (4-HD), and xanthoangelol (XAG) promote glucose uptake and GLUT4 translocation in L6 myotubes, but their underlying molecular mechanism remains unclear. This study investigates the mechanism in L6 myotubes and confirms antihyperglycemia by 4-HD and XAG.
Methods and results: In L6 myotubes, 4-HD and XAG promote glucose uptake and GLUT4 translocation through the activation of adenosine monophosphate-activated protein kinase (AMPK) and liver kinase B1 (LKB1) signaling pathway without activating phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) and Janus kinases (JAKs)/signal transducers and activators of transcriptions (STATs) pathways. Moreover, Compound C, an AMPK-specific inhibitor, as well as siRNA targeting AMPK and LKB1 completely canceled 4-HD and XAG-increased glucose uptake. Consistently, oral administration of 4-HD and XAG to male ICR mice suppresses acute hyperglycemia in an oral glucose tolerance test.
Conclusion: In conclusion, LKB1/AMPK pathway and subsequent GLUT4 translocation in skeletal muscle cells are involved in Ashitaba chalcone-suppressed acute hyperglycemia.
Keywords: 4‐hydroxyderricin; AMPK; Angelica keiskei Koidzumi (Ashitaba); GLUT4; xanthoangelol.
© 2024 Wiley‐VCH GmbH.
References
-
- N. S. Mitchell, V. A. Catenacci, H. R. Wyatt, J. O. Hill, Psychiatr. Clin. North Am. 2011, 34, 717.
-
- Y. Zheng, S. H. Ley, F. B. Hu, Nat. Rev. Endocrinol. 2017, 14, 88.
-
- P. Saeedi, I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin, S. Colagiuri, L. Guariguata, A. A. Motala, K. Ogurtsova, J. E. Shaw, Diabetes Res. Clin. Pract. 2019, 157, 107843.
-
- P. V. Röder, B. Wu, Y. Liu, W. Han, Exp. Mol. Med. 2016, 48, e219.
-
- T. Wang, J. Wang, X. Hu, X. J. Huang, G. X. Chen, World J. Biol. Chem. 2020, 11, 76.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
